Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma
Open Access
- 3 January 2008
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 6 (1) , 1
- https://doi.org/10.1186/1479-5876-6-1
Abstract
Background: Nasopharyngeal carcinoma (NPC) is one of the most common malignancies in southern China. The China 1992 TNM staging system has been widely used for prognosis prediction of NPC patients in China. Although NPC patients can be classified according to their clinical stage in this system, their prognosis may vary significantly. Method: 280 cases of NPC with clinical follow-up data were collected and expressions of survivin and VEGF in tumor tissues were investigated by immunohistochemistry (IHC). Apoptosis index (AI) in 100 cases of NPC was detected by the TUNEL method. Results: Expression of survivin and VEGF were significantly associated with TNM stage, T-stage and metastasis of NPC. The patients with survivin and VEGF over-expression presented lower 5-year survival rate, as compared to those of low-expression (42.32% vs. 70.54%, 40.1% vs. 67.8%, respectively, P < 0.05), especially in advanced stage patients (36.51% vs. 73.41%, 35.03% vs. 65.22%, respectively, P < 0.05). The 5-year survival rate in NPC patients with survivin and VEGF dual over-expression was significantly lower than that of patients with dual low-expression (18.22% vs. 73.54%, respectively; P = 0.0003). Multivariate analysis indicated that both survivin and VEGF over-expression in NPC tumor tissues were strong independent factors of poor prognosis in NPC patients. The mean AI in the 39 survivin low-expression cases was 144.7 ± 39.9, which was significantly higher than that in 61 survivin over-expression cases (111.6 ± 39.8) (T test, P < 0.05). Conclusion: Survivin and VEGF over-expression are independent prognostic factors for the patients with NPC. These results also suggest that tumor survivin and VEGF expressions are valuable prognostic markers for prognosis prediction in NPC patients.Keywords
This publication has 55 references indexed in Scilit:
- Prognostic Significance of the Epstein-Barr Virus, p53, Bcl-2, and Survivin in Nasopharyngeal CancerClinical Cancer Research, 2006
- Prognostic Value of Survivin and Livin in Nasopharyngeal CarcinomaThe Laryngoscope, 2006
- Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV statusVirus Research, 2006
- Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-regulates VEGF and TGFα Concomitant with Hyperlasia, with Subsequent Up-regulation of p16 and MMP9Cancer Research, 2005
- VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancerLung Cancer, 2004
- Clinical relevance of amphiregulin and VEGF in primary breast cancersInternational Journal of Cancer, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Survivin Expression in Ovarian Carcinoma: Correlation with Apoptotic Markers and PrognosisLaboratory Investigation, 2003
- Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implicationsThe Lancet Oncology, 2001
- Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell deathCell, 1995